EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Clinical trial NCT06401421 · RECRUITING
Trial details
- NCT number
- NCT06401421
- Sponsor
- Exact Sciences Corporation
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-06-07
- Primary completion
- 2030-04-01
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.